Liquid crystal composition, liquid crystal display device including the same, and method of manufacturing liquid crystal display device
US-2017210994-A1 · Jul 27, 2017 · US
US10041001B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10041001-B2 |
| Application number | US-201615204290-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 7, 2016 |
| Priority date | Jan 21, 2016 |
| Publication date | Aug 7, 2018 |
| Grant date | Aug 7, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A liquid crystal composition including: a liquid crystal compound and a liquid crystal aligning agent containing at least one compound represented by Formula 1: wherein in the Formula 1, X—*, *-L 1 -*, *-L 2 -*, *-L 3 -*, *—C—*, *—R—*, Y—*, n 1 , n 2 , and m is the same as defined in the specification.
Opening claim text (preview).
What is claimed is: 1. A liquid crystal composition, comprising: a liquid crystal compound; and a liquid crystal aligning agent comprising at least one compound represented by Formula 1: wherein in Formula 1, X—* is C 1-20 -alkyl-*, -L 1 -* is a single bond, *—(CH 2 ) p1 —*, *—O(CH 2 ) p1 —*, *—O—*, *—CH═CH—*, *—C≡C—* (wherein p1 is an integer of 1 to 10), or a combination thereof; *-L 2 -* is a single bond, *—(CH 2 ) p2 —*, *—O(CH 2 ) p2 —*, *—O—*, *—CH═CH—*, *—C≡C—* (wherein p2 is an integer of 1 to 10), or a combination thereof; *-L 3 -* is a single bond, *—(CH 2 ) p3 —*, *—O(CH 2 ) p3 —*, *—O—*, *—CH═CH—*, *—C≡C—* (wherein p3 is an integer of 1 to 10), or a combination thereof; *-L 1 -*, *-L 2 -*, and *-L 3 -* are identical to or different from one another; *—C—* is a substituted or unsubstituted cyclic linking group selected from substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted substituted or unsubstituted and substituted or unsubstituted wherein at least one hydrogen in the substituted cyclic linking group is substituted with C 1-10 -alkyl-*, F—*, Br—*, I—*, *—OH, *—NH 2 , or (meth)acryloxy-C 1-10 -alkyl-*; *—R—* is *—(CH 2 ) q —*, *—O(CH 2 ) q —*, *—(CH 2 ) q Arn-*, or *—O(CH 2 ) q Arn-* (wherein Arn is a substituted or unsubstituted C 6-30 arylene, and q is an integer of 1 to 10), wherein at least one hydrogen in the substituted C 6-30 arylene is substituted with C 1-10 -alkyl-*, F—*, Br—*, I—*, *—OH, *—NH 2 , or (meth)acryloxy-C 1-10 -alkyl-*; Y—* is (wherein n is an integer of 0 to 5); n 1 is an integer of 1 to 3, and n 2 and m are each independently 0 or 1. 2. The liquid crystal composition of claim 1 , wherein X—* is C 1-20 -alkyl-*, and wherein the liquid crystal composition further comprises a reactive mesogen comprising at least one compound represented by Formula 2: P1-SP1-MG-SP2-P2 Formula 2 wherein in Formula 2, P1-* and P2-* are each independently —SP1-* is (wherein a is an integer of 0 to 2) and *—SP2-* is (wherein b is an integer of 0 to 2), wherein each *-L-* is independently *—(CH 2 ) c —*, *—O(CH 2 ) c —*, *—CH═CH—*, or *—C≡C—* (wherein c is an integer of 1 to 10), *—Z—* is *—(CH 2 ) d —* (wherein d is an integer of 0 to 12), and *—Ar—* is (wherein each A-* is H—*, C 1-10 -alkyl-*, F—*, Br—*, I—*, *—OH, *—NH 2 , or CN—*); and *-MG-* is (wherein each A-* is H—*, C 1-10 -alkyl-*, F—*, Br—*, I—*, *—OH, *—NH 2 , or CN—*). 3. The liquid crystal composition of claim 2 , wherein the liquid crystal aligning agent comprises at least one compound represented by Formulae SA 1-1 to SA 1-8: 4. The liquid crystal composition of claim 1 , wherein the liquid crystal aligning agent comprises the compound represented by Formula 1, wherein X—* is wherein the liquid crystal composition does not include a reactive mesogen comprising at least one compound represented by Formula 2: P1-SP1-MG-SP2-P2 Formula 2 wherein in Formula 2, P1-* and P2-* are each independently —SP1-* is
Other substituted melamines · CPC title
with an oxygen or sulfur atom attached to the third ring carbon atom · CPC title
attached in position 3 or 5 · CPC title
containing boron or phosphorus · CPC title
the heterocyclic ring being a six-membered aromatic ring containing at least three nitrogen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.